Nicotinamide riboside alleviates brain dysfunction induced by chronic cerebral hypoperfusion via protecting mitochondria
Biochemical Pharmacology · 2024
DOI: 10.1016/j.bcp.2024.116272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Pharmacology, 2024. Verfasst von Lina Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China; Department of Microbiology and Immunology, Schoo…. Hauptthemen laut MEDLINE: Niacinamide, Mitochondria, Pyridinium Compounds, Neuroprotective Agents. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Chronic cerebral hypoperfusion (CCH) is an enduring inadequate blood flow to the brain, resulting in vascular dementia (VaD). However, the effective treatment strategies are lacking. Supplementing with nicotinamide adenine dinucleotide (NAD+) has shown neuroprotective benefits in other neurodegenerative disorders. Nicotinamide riboside (NR), as a precursor of NAD+, is believed to hold promise in improving mitochondrial health, autophagy, and cognitive function. Meanwhile, NR has unique oral bioavailability, good tolerability, and minimal side effects, and it is the most promising for clinical translation. However, the effectiveness of NR in treating CCH-related VaD is still uncertain. The present study examined the neuroprotective effects of NR supplementation and its underlying mechanisms in a CCH rat model. The rats with CCH were given NR at a daily dosage of 400 mg/kg for 3 months. NR supplementation increased blood and brain NAD+ levels and improved brain function in CCH rats, including cognitive function and oxygenation capacity. It also reduced hippocampal neuronal loss and abnormalities and mitigated the decrease in dendritic spine density. The analysis of RNA sequencing in hippocampal tissue supports these findings. Electron microscopy and protein detection results suggest that NR may maintain mitochondrial structural integrity and exert a protective role by attenuating mitochondrial fission and impaired autophagy flux caused by CCH. In conclusion, these findings offer evidence for the neuroprotective potential of NR supplementation in ameliorating cognitive impairment induced by CCH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China; Department of Microbiology and Immunology, School of Medicine, Institute of Geriatric Immunology, Jinan University, Gu…
- Department of Microbiology and Immunology, School of Medicine, Institute of Geriatric Immunology, Jinan University, Guangzhou 510632, China; Key Laboratory of Viral Pathogenesis & Infection Prevention and Control (Jinan…
- Department of Neurology, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China. Electronic address: tlian@jnu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, L., Peng, T., Deng, J., Gao, W., Wang, H., Junhong Luo, O., Huang, L., & Chen, G. (2024). Nicotinamide riboside alleviates brain dysfunction induced by chronic cerebral hypoperfusion via protecting mitochondria. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2024.116272
Vancouver
Wang L, Peng T, Deng J, Gao W, Wang H, Junhong Luo O, et al. Nicotinamide riboside alleviates brain dysfunction induced by chronic cerebral hypoperfusion via protecting mitochondria. Biochemical Pharmacology. 2024. doi:10.1016/j.bcp.2024.116272
BibTeX
@article{Wang2024,
author = {Wang, Lina and Peng, Tianchan and Deng, Jieping and Gao, Wen and Wang, Haoyun and Junhong Luo, Oscar and Huang, Li'an and Chen, Guobing},
title = {Nicotinamide riboside alleviates brain dysfunction induced by chronic cerebral hypoperfusion via protecting mitochondria},
journal = {Biochemical Pharmacology},
year = {2024},
doi = {10.1016/j.bcp.2024.116272}
}
EUVIMED